FREDERICTON (GNB) – The provincial government will resume using the Agriflu influenza vaccine following Health Canada’s decision to lift its suspension of the product.
Use of the seasonal influenza vaccine had been temporarily suspended as a precautionary measure following reports of clumping of particles in the vaccine in Europe. A review by Health Canada found no safety issues and determined that the one lot of Agriflu that showed clumping of particles was not released to the market.

“Now that the review is complete and Health Canada has released Agriflu for use across the country, New Brunswick health-care providers will resume using the vaccine,” said Chief Medical Officer of Health Dr. Eilish Cleary. “Vaccination is recognized as the single most effective way of reducing the impact of seasonal influenza and New Brunswickers should be assured of the quality of the Agriflu vaccine.”

As part of the review, Health Canada looked at the results of its own testing, conducted a health risk assessment and reviewed information from its European partners and data submitted by drug manufacturer Novartis.

More information is also available on the Health Canada web site.